|
MORE DETAILS
|
WEEKLY COMMENT
|
Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.
|
|
MedComms Networking - 27 February 2024
Hi
So, shall we take a break from talking about AI in MedComms? Just briefly.
Tomorrow's webinar is about turning stress into a force for good, with Paul Hutchings of fox&cat) and Catherine Keddie of CK Coaching and Consulting. Maybe, together, we can create an industry where the natural levels of pressure and stress that come with the role are used as a force for good, rather than us feeling crushed by it. What do you think? Join us. Everyone's welcome. It's another webinar that could work well if you gather your colleagues, share cake and use the opportunity to discuss how you support each other.
Of course, AI is now the very cause of stress for some!
In last week's webinar, we talked about using tech to help de-silo the pharma industry. As we stopped recording, panelist Dan Gibbs of 9Labs proudly applauded how we hadn't mentioned AI! We then proceeded to argue about what we mean by AI in the first place...
The confusion around quite what AI means to different people, and the implications in practice, I think are nicely illuminated in the various and somewhat conflicting comments in a LinkedIn discussion I posted a week ago. An article had been published in a Springer Journal, Infectious Diseases and Therapy and in the Acknowledgements section the authors acknowledged how ChatGPT version 3.5 was used to check for English grammar and style of the final version of the manuscript. The fact that the AI - but importantly also the humans involved - hadn't caught the typos maybe raises some valid points to ponder, but the comments provide even more to think around.
Next week, we'll focus in on the practicalities of ensuring ethical and authentic use of AI in healthcare comms with Joe Hance, Jon Hume and Philippa Pristera from Cuttsy+Cuttsy discussing practicalities from developing their own ethical framework.
Then on Wednesday 13 March we'll go large! Zayed Yasin and Sam Pitkeathly from Writer, will reflect on how we are transforming the way Healthcare Businesses Communicate using Enterprise-Level Generative AI. That could be interesting. Did you see this news item a few days ago, With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing"?" They report "Executives say it's still early, but the platform is now in use by Pfizer's hundreds of people in central marketing team and thousands across the company's various brands. It's also being used by agency partners including Publicis Groupe and IPG."
Food for thought?
Stay well, everyone. There's lots more coming. After Easter, I promise we'll do more to get away from talking about AI. But for now it's just such fun, don't you think?
P.S. Did you see, yesterday we announced an EXTRA #MedComms webinar? On 14 March, we'll explore Using Copilot in MedComms: The Good and the Not So Good News. More than 100 registrations within 2 hours of the announcement suggests interest levels may be high. Everyone's welcome. Please encourage all relevant others to join us.
Cheers
Peter Llewellyn
Managing Director, NetworkPharma Ltd
Follow me on LinkedIn @NetworkPharma
Join more than 8,000 international colleagues in the MedComms Networking Linkedin Group
The information at MedCommsNetworking.com is always bang up-to-date!
|
|
|
|
